Susceptibility-guided sequential therapy shows no superiority over empirical therapy for H. pylori eradication
Susceptibility-guided therapy did not beat standard treatment for stomach bug infections
This randomised controlled trial in 500 treatment-naive adults with H. pylori infection compared susceptibility-guided sequential therapy to…
A new trial found that testing for drug resistance before treatment did not improve cure rates compared to standard care for stomach infecti…
H. pylori prevalence reaches 77.2% in Vietnamese children and 58.7% in adults across 8204 and 4641 participants respectively
Nearly 80 percent of Vietnamese children carry this stomach bacteria
This systematic review and meta-analysis assesses Helicobacter pylori infection prevalence among Vietnamese adults and children. The pooled …
A large review found that 77.2 percent of Vietnamese children have Helicobacter pylori infection, while 58.7 percent of adults are affected.
WeChat-based patient-doctor interaction improves patient experience in H. pylori infection treatment
A WeChat chat group did not improve stomach bug cure rates compared to standard care
This randomized controlled trial evaluated a WeChat-based patient-doctor interaction system versus routine patient education in treatment-na…
A chat group with doctors did not cure more stomach bugs than standard education, though patients felt better using the app.
Narrative review of vonoprazan for pediatric H. pylori infection
New drug class could simplify hard-to-treat stomach infections in kids
This narrative review synthesizes evidence on vonoprazan-based regimens for Helicobacter pylori infection in pediatric populations. The auth…
A new stomach acid blocker might help clear infections in kids, but doctors need more proof before using it widely.
Bismuth quadruple therapy shows higher H. pylori eradication in pediatric patients with clarithromycin resistance
High-Level Clarithromycin Resistance May Predict Bismuth Success in H. pylori
This observational study of 4,610 pediatric patients with H. pylori infection compared bismuth quadruple therapy to triple therapy. Bismuth …
A simple blood test level may predict which H. pylori infections respond best to bismuth therapy, turning a treatment failure sign into a gu…
Meta-analysis: Nitazoxanide triple therapy improves H. pylori eradication vs standard triple therapy
Nitazoxanide triple therapy significantly improves H. pylori cure rates compared to standard treatment
This systematic review and meta-analysis of 1286 participants found that nitazoxanide-based triple therapy significantly improved H.
A large review of 1286 patients found that adding nitazoxanide to standard triple therapy significantly improved H. pylori cure rates and re…
H. pylori prevalence 34.3% in French Guiana; gastric adenocarcinoma found in 1.65%
One Third of Stomach Tests Show Hidden Bacteria Risk
A retrospective cohort study of 545 patients with H.
A new look at stomach biopsies shows one in three patients carry a hidden bacteria that can lead to serious disease.
Retrospective study compares antibiotic regimens for H. pylori eradication in children
Two antibiotic regimens cleared H. pylori in most children within four weeks
This retrospective observational study evaluated two antibiotic combinations for treating Helicobacter pylori infection in children aged 4 t…
A look at two common treatments found that both regimens successfully eliminated the bacteria in most children within four weeks.
Bismuth-containing quadruple therapy associated with higher H. pylori eradication rates compared to triple therapy in children
New Mix Clears Stomach Bugs Better in Children
This retrospective cohort study of 161 pediatric patients compared 14-day bismuth-containing quadruple therapy against triple therapy for He…
A four-drug plan works better than the usual three-drug plan for clearing stomach bacteria in kids.
Monoclonal stool antigen test shows high accuracy for H. pylori detection in chronic atrophic gastritis patients
A Simple Stool Test Spots a Dangerous Stomach Bug Without a Scope
This prospective primary care study evaluated 287 patients with chronic atrophic gastritis (CAG) using a monoclonal stool antigen test (SAT)…
A simple stool test spots dangerous stomach bugs in people with chronic gastritis, performing even better when the stomach is most at risk.
Meta-analysis finds vonoprazan-based therapies achieve 94% H. pylori eradication in Asian populations
The Two-Drug Combo Clearing Stomach Bacteria Where Others Are Failing
A systematic review and meta-analysis of 7,498 Asian patients with Helicobacter pylori infection compared vonoprazan-amoxicillin regimens to…
A new two-drug combo clears stomach bacteria in 94% of Asian patients, outperforming standard treatments where others are failing.
Gastotypes predict Helicobacter pylori infection status in gastric mucosal samples with high accuracy
New Stomach Map Reveals Four Hidden Types
This cohort study analyzed 566 gastric mucosal samples to identify microbial community types associated with Helicobacter pylori infection s…
New stomach map reveals four distinct bacterial neighborhoods, showing stool tests cannot tell the real story happening inside your stomach …
Questions about Helicobacter pylori infection
How does clarithromycin resistance affect the success of treating Helicobacter pylori infection in pediatric patients?
Clarithromycin resistance significantly lowers H. pylori eradication success in children, but bismuth-based quadruple therapy or tailored regimens can overcome this resistance.
Full answer →Which antibiotic regimens are being compared to treat Helicobacter pylori infection in children aged 4 to 13 years?
In children aged 4–13 years, studies compare triple therapy (PPI + amoxicillin + clarithromycin or PPI + metronidazole + clarithromycin) versus bismuth-containing quadruple therapy (adding bismuth).
Full answer →Do vonoprazan-based therapies cure Helicobacter pylori infection in 94% of Asian patients according to recent studies?
Yes, a 2025 meta-analysis found vonoprazan-based therapies achieve 94% eradication in Asian patients, but real-world rates vary.
Full answer →Can a stool antigen test accurately find Helicobacter pylori infection in patients with chronic atrophic gastritis?
Yes, a monoclonal stool antigen test is a reliable non-invasive tool for detecting H. pylori in chronic atrophic gastritis, with high specificity and strong diagnostic consistency.
Full answer →Does bismuth quadruple therapy work better than triple therapy for kids with Helicobacter pylori infection?
Yes, bismuth quadruple therapy works better than triple therapy for H. pylori eradication in children, with higher success rates especially when clarithromycin resistance is present.
Full answer →All Helicobacter pylori infection Articles
- Susceptibility-guided sequential therapy shows no superiority over empirical therapy for H. pylori eradication
- H. pylori prevalence reaches 77.2% in Vietnamese children and 58.7% in adults across 8204 and 4641 participants respectively
- WeChat-based patient-doctor interaction improves patient experience in H. pylori infection treatment
- Narrative review of vonoprazan for pediatric H. pylori infection
- Bismuth quadruple therapy shows higher H. pylori eradication in pediatric patients with clarithromycin resistance
- Meta-analysis: Nitazoxanide triple therapy improves H. pylori eradication vs standard triple therapy
- H. pylori prevalence 34.3% in French Guiana; gastric adenocarcinoma found in 1.65%
- Retrospective study compares antibiotic regimens for H. pylori eradication in children
- Bismuth-containing quadruple therapy associated with higher H. pylori eradication rates compared to triple therapy in children
- Monoclonal stool antigen test shows high accuracy for H. pylori detection in chronic atrophic gastritis patients
- Meta-analysis finds vonoprazan-based therapies achieve 94% H. pylori eradication in Asian populations
- Gastotypes predict Helicobacter pylori infection status in gastric mucosal samples with high accuracy
- Meta-analysis of 19,941 participants shows 83.0% eradication rates for Helicobacter pylori antibiotic regimens
- Vonoprazan-based regimens show higher H. pylori eradication rates than rabeprazole dual therapy in Chinese cohort
- H. pylori eradication reduces gastric cancer risk by up to 44%, per guideline review
- Genetic study links H. pylori susceptibility to HLA and innate immunity genes, suggests causal disease relationships